arBtrage CAPITALIZING MARKETS checking… Sign in

Viridian Therapeutics, Inc.

VRDN Health Care Medical Specialities
$15.78
▼ -4.8% Today
as of Jun 7, 07:31 ET
Last 30 days +15.94% Apr 28 → Jun 05
$12.86 $14.44 $16.03 $17.61 $19.19 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$16.57
High
$16.88
Low
$15.57
Volume
$2M
Avg Vol
$2M
Mkt Cap
$1.8B
P/E (TTM)
Beta
52w High
$34.29
52w Low
$13.18
Div Yield
Shares Out
$102M

Overview

52-week range
$13
$34
12% of range
Avg surprise (last 2)
+11.8%
Avg reaction (last 2)
+12.5%
50% positive
Latest IV / EM
160%
EM ±22.2% · $16 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.27$-1.15$-1.03$-0.91$-0.79 Actual $-1.27Actual $-1.09Actual $-0.79Actual $-1.02Actual $-1.15Actual $-0.87Est $-0.95Actual $-0.90Est $-1.06 JunSepMarJunSepMar/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-105M$-88M$-71M$-53M$-36M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.90 $-1.06 +15.1% -3.5% +33.4% earnings
Tue May 6, 2025Mar/2025 $-0.87 $-0.95 +8.4% -8.3% earnings
Mon Sep 30, 2024Sep 2024 $-1.15 financials
Sun Jun 30, 2024Jun 2024 $-1.02 financials
Sun Mar 31, 2024Mar 2024 $-0.79 financials
Sat Sep 30, 2023Sep 2023 $-1.09 financials
Fri Jun 30, 2023Jun 2023 $-1.27 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-116M$-40M$-107M$-94M$-83M$-72M
Net income$-105M$-35M$-101M$-87M$-77M$-65M
EPS (diluted)$-1.15$-1.02

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents
Inventory
Total current assets$785M$894M$572M$579M$657M$738M$767M$582M
Total assets$789M$899M$577M$582M$661M$742M$772M$586M
Long-term debt$21M$12M$21M$21M$21M$17M
Total liabilities$153M$177M$74M$67M$57M$71M$64M$56M
Total equity$636M$722M$503M$515M$604M$672M$707M$529M

Implied volatility — last 90 days

155%157%160%162%165% Jun 07 — IV 160% · EM ±22.2%

Sector peers